METHODS
We undertook a retrospective study of the case notes of patients seen in the glaucoma unit of Moorfields Eye Hos pital over the last 3 years with a diagnosis of pseudophakic malignant glaucoma.
RESULTS
Seven subjects were identified -a figure that reflects the rarity of the condition since over the 3-year study period in excess of 12,000 cataract extractions had been performed.
Six were female, and the mean age at presentation Was 67 years (range 59-78 years). The mean follow-up was 9 months with only 1 patient seen for less than 6 months.
Examination of the ocular features of this group revealed that of the 7 eyes, 5 were already on treatment for glaucoma (2 for primary open angle glaucoma, 2 for chronic narrow angle glaucoma and 1 had had previous acute angle closure glaucomil) and had all undergone pre vious glaucoma surgery. One of the remaining 2 eyes had pseudoexfoliation and only 1 eye of the group could be described as normal.
The mean axial length of the 5 eyes for which the measurement was available was 21.1 mm; 4 of them were less than 21.0 mm. Four of the 7 eyes were 'only eyes', although none of the 4 affected fellow eyes had suffered from malignant glaucoma: 2 of them had suffered compli cations following cataract surgery, 1 had suffered perman ent visual loss following an attack of acute angle closure glaucoma, and the fourth was phthisical from an unknown cause.
The surgical procedure that preceded the development of malignant glaucoma was extracapsular cataract extrac tion in 4 patients, glaucoma triple procedures in 2, and tra beculectomy in 1 whose eye was already pseudophakic.
All had posterior chamber intraocular lenses.
The latency between surgery and onset of malignant glaucoma was variable. Four cases presented between 1 and 2 weeks post-operatively, 2 at 7 weeks and 1 was diag nosed at 7 months. The clinical courses of the 7 cases are summarised in Table 1 .
At presentation, a retrocapsular collection of aqueous was noted in 6 of the 7 cases and all 7 received full medical treatment to establish control of the acutely raised intra ocular pressure. This consisted of intensive topical steroid, beta blocker, mydriatic and cycloplegic, systemic car bonic anhydrase inhibitor and oral hyperosmotic agents if required.
All 7 eyes received a Nd:YAG capsulotomy: in 3 cases There was a mean improvement in corrected visual acuity of three Snellen lines at final follow-up and no patient had worse acuity than pre-operatively. All 7 eyes corrected to 6/18 or better (3 to 6/18, 3 to 6/12 and 1 to 6/9).
The mean intraocular pressure was 20.1 mmHg. This average concealed an underlying bimodal distribution, with the intraocular pressure of 5 of the 7 eyes between 10 and 20 mmHg but the remaining 2 unsatisfactorily high at 30 and 32 mmHg. We found that Nd:YAG laser posterior capsulotomy is an effective treatment in pseudophakic malignant glau coma and was successful in stabilising the intraocular pressure in 5 of the 7 eyes so treated. We recommend it as a first-line treatment for this condition as it is an effective and minimally invasive procedure that can delay and sometimes obviate the need for acute surgical intervention.
